Faculty of medicine and health, Medical school in Juiz de Fora, Brazil

Commonly used medications for type 2 diabetes and obesity called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), are not associated with an increased risk of breast cancer, despite previous studies that suggested a possible link, according to a study presented by the Endocrine Society."GLP-1RAs can be used as an adjunct to diet and exercise in subjects with type 2 diabetes and those without type 2 diabetes and excess weight, without an increased risk of breast cancer or noncancerous masses in the breast," said lead researcher Giovana Fagundes Piccoli, M.D., of the Universidade Federal do the Rio Grande do Sul in Brazil.GLP-1 RAs have been shown to be effective in treating obesity and type 2 diabetes and in reducing heart disease. These drugs include albiglutide (Tanzeum); dulaglutide (Trulicity); exenatide (Byetta); extended-release exenatide (Bydureon); liraglutide (Victoza, Saxenda); lixisenatide (Adlyxin); and semaglutide (Ozempic, Rybelsus).In clinical trials of liraglutide, subjects treated with the active drug instead of a placebo had a higher number of breast cancers. The new study was designed to assess whether patients treated with GLP-1 RAs had a higher risk of breast cancer or benign growths in the breasts called neoplasms.Piccoli reviewed 52 randomized controlled trials that compared GLP-1 RAs with non-GLP-1 RAs (either other diabetes or weight-loss drugs or placebos) in adults with overweight, obesity, prediabetes or diabetes. The studies had a minimum follow-up period of 24 weeks and reported at least one event of breast cancer or benign breast neoplasm. They included a total of 90,360 participants.The analysis found treatment with GLP-1 RAs was not associated with increased rates of breast cancer or benign or premalignant breast neoplasms, compared to placebo or other diabetes or weight-loss drugs. Among 48,267 subjects treated with GLP-1 RAs, 130 developed breast cancer, compared to 107 of 40,755 controls.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Faculty Of Medicine And HealthFOLLOW

Faculty of medicine and health, Latest News

Brasilia, March 30 Brazilian Defence Minister Fernando Azevedo e Silva announced his resignation, without giving a reason for ... ...

Lisbon, March 30 The Portuguese government has announced that all flights to and from Brazil and the UK ... ...

Dr Ajit Bhagwat The rapid surge of the second wave of Covid-19 has taken every one by a shocking ... ...

Brasilia, March 28 For two consecutive days, Brazil, currently the second worst-hit country in the world after the ... ...

During a recent study, a team of researchers in Brazil through various machine learning methods taught a computer program to detect COVID-19 in chest X-rays with 95.6 to 98.5 per cent accuracy. ...

Aurangabad, March 25: Aurangabad has been listed as the first city in Maharashtra due to the rise in the ... ...

New Delhi, March 22 Auto companies may soon be asked to manufacture passenger and commercial vehicles that run ... ...

Commonly used medications for type 2 diabetes and obesity called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), are not associated with an increased risk of breast cancer, despite previous studies that suggested a possible link, according to ...